Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Meltzer, C. C. Articles by Reynolds, C. F. Search for Related Content PubMed Citation Articles by Meltzer, C. C. Articles by Reynolds, C. F., III Neurotransmitters Geriatric Psychiatry Depression Alzheimer's Disease PET Neurodegeneration

PET Imaging of Serotonin Type 2A Receptors in Late-Life Neuropsychiatric Disorders

OBJECTIVE: To determine whether there are abnormalities in the in vivo status of the serotonin type 2A (5-HT_2A) receptor in late-life depression and Alzheimer’s disease, the authors used positron emission tomography (PET) to assess patients with these two conditions and healthy subjects. METHOD: PET was performed by using [¹⁸F]altanserin to evaluate 5-HT_2A receptor binding in 11 elderly patients with depression (four men, seven women; mean age=65.0 years, SD=5.5); nine Alzheimer’s disease patients, including three with concurrent depression (two men, seven women; mean age=69.7 years, SD=5.0); and 10 age-matched healthy subjects (four men, six women; mean age=69.8 years, SD=5.0). Partial-volume correction of regional specific binding estimates was performed by using a method based on magnetic resonance imaging. RESULTS: No significant abnormalities in [¹⁸F]altanserin binding (binding potential) were observed in the patients with late-life depression, and no effect of depression on binding potential was present within the Alz­heimer’s disease group. However, the patients with Alzheimer’s disease had significantly lower binding than the normal subjects in several brain regions, including the anterior cingulate, prefrontal cortex, and sensorimotor cortex. CONCLUSIONS: These results suggest that the 5-HT_2A receptor is differentially affected in late-life depression and Alzheimer’s disease, a finding that has implications for the etiological basis of mood and cognitive features of neuropsychiatric disorders of late life.

This article has been cited by other articles:

				K HERHOLZ, S F CARTER, and M JONES Positron emission tomography imaging in dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S160 - S167. [Abstract] [Full Text] [PDF]

				D. A. Hammoud, J. M. Hoffman, and M. G. Pomper Molecular Neuroimaging: From Conventional to Emerging Techniques Radiology, October 1, 2007; 245(1): 21 - 42. [Abstract] [Full Text] [PDF]

				A. M. Landes, S. D. Sperry, and M. E. Strauss Prevalence of Apathy, Dysphoria, and Depression in Relation to Dementia Severity in Alzheimer's Disease J Neuropsychiatry Clin Neurosci, August 1, 2005; 17(3): 342 - 349. [Abstract] [Full Text] [PDF]

				J. H. Meyer, S. Houle, S. Sagrati, A. Carella, D. F. Hussey, N. Ginovart, V. Goulding, J. Kennedy, and A. A. Wilson Brain Serotonin Transporter Binding Potential Measured With Carbon 11-Labeled DASB Positron Emission Tomography: Effects of Major Depressive Episodes and Severity of Dysfunctional Attitudes Arch Gen Psychiatry, December 1, 2004; 61(12): 1271 - 1279. [Abstract] [Full Text] [PDF]

				N. Rasgon and L. Jarvik Insulin Resistance, Affective Disorders, and Alzheimer's Disease: Review and Hypothesis J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2004; 59(2): M178 - 183. [Abstract] [Full Text] [PDF]

				J. H. Meyer, S. McMain, S. H. Kennedy, L. Korman, G. M. Brown, J. N. DaSilva, A. A. Wilson, T. Blak, R. Eynan-Harvey, V. S. Goulding, et al. Dysfunctional Attitudes and 5-HT2 Receptors During Depression and Self-Harm Am J Psychiatry, January 1, 2003; 160(1): 90 - 99. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 1999 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us